高浓度富血小板血浆与安慰剂治疗拇指基底部骨关节炎:评估者盲法随机对照试验研究方案
本研究为随机双盲对照试验,计划从斯德哥尔摩Södersjukhuset医院手外科招募90例拇指基底部骨关节炎患者,比较影像引导下高浓度富血小板血浆注射与生理盐水安慰剂在减轻疼痛和改善功能方面的效果,主要结局为6个月时负重疼痛数字评分,随访至12个月。
要点
- 高浓度富血小板血浆与生理盐水安慰剂在拇指基底部骨关节炎中的疗效对比尚缺乏证据。
- 主要结局为注射后6个月负重疼痛数字评分,次要结局包括患者报告结局、捏力、握力、拇指外展及1年内干预时间。
- 若富血小板血浆优于生理盐水,可能成为有前景的替代治疗;若无显著获益,则其应用不合理。
核心结论
- 研究旨在提供高浓度富血小板血浆注射治疗拇指基底部骨关节炎疗效的证据。
- 若富血小板血浆在减轻疼痛和改善功能方面优于生理盐水,可能提供有前景的替代治疗。
- 反之,若富血小板血浆未显示优于安慰剂的显著获益,则其用于该病症不合理。
研究设计与样本
- 随机双盲对照试验,计划样本量90例,从斯德哥尔摩Södersjukhuset医院手外科招募符合纳入标准的患者。
- 注射在无菌条件和影像引导下进行,评估者盲法。
- 随访时间为注射后3、6和12个月。
- 主要结局为6个月时负重疼痛数字评分;次要结局包括患者报告结局、捏力、握力、拇指外展及1年内干预时间。
- 统计分析采用非参数检验、卡方检验和广义估计方程比较富血小板血浆组与安慰剂组。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteoarthritis in the thumb base (trapeziometacarpal joint, CMC-1 joint) is prevalent, particularly among middle-aged and elderly women, causing significant disability. Conservative treatments, including steroid injections, have been questioned for their efficacy, prompting exploration into alternative therapies such as platelet-rich plasma (PRP) injections. This randomized, double-blinded, controlled trial aims to evaluate the effectiveness of high-concentration PRP (platelet-rich plasma) injection compared to saline (placebo) in reducing pain and disability in patients with thumb base osteoarthritis. METHODS: Patients meeting inclusion criteria will be randomized and blinded, with injections administered under sterile conditions and radiological guidance. With a planned sample size of 90 patients recruited from the Department of Hand Surgery at Södersjukhuset, Stockholm, the study will assess pain relief and functional improvement at 3, 6, and 12 months post-injection. The primary outcome measure is pain on load (numerical rating scale) at 6 months, with secondary outcomes including patient-reported outcomes, key pinch, grip strength, abduction of the thumb, and time to intervention within 1 year. Statistical analyses will employ non-parametric tests, chi-square tests, and generalized estimating equations to compare outcomes between the PRP and placebo groups. DISCUSSION: The study aims to provide evidence regarding the efficacy of high-concentration PRP injections for thumb base osteoarthritis. If PRP proves superior to saline in reducing pain and improving function, it could offer a promising alternative treatment. Conversely, if PRP does not demonstrate significant benefits over placebo, its use for this condition is not justified. This study seeks to address the current gap in evidence regarding the efficacy of PRP injections for thumb base osteoarthritis. TRIAL REGISTRATION: The study has been approved by the Swedish Ethical Review Authority (2023-06860-01 and 2024-01238-02) and is registered on ClinicalTrials.gov (NCT06193499) 2024-01-04.
引用
- von Kieseritzky J, Wilcke M. High-concentrated platelet-rich plasma (PRP) versus placebo in osteoarthritis in the thumb base: study protocol for an assessor-blinded randomized controlled trial. Trials. 2024. PMID: 39587622. doi:10.1186/s13063-024-08636-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。